Method and apparatus for transcutaneous facial nerve stimulation and applications thereof
US-12179011-B2 · Dec 31, 2024 · US
Extracranial implantable devices, systems and methods for the treatment of neuropsychiatric disorders
US8958880B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-8958880-B2 |
| Application number | US-89868510-A |
| Country | US |
| Kind code | B2 |
| Filing date | Oct 5, 2010 |
| Priority date | Oct 5, 2009 |
| Publication date | Feb 17, 2015 |
| Grant date | Feb 17, 2015 |
How to read this patent
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
- Title
What the patent document calls the invention.
- Abstract
A short plain-language summary of the technical disclosure.
- Assignees and inventors
Who owns or filed the patent and who is credited as inventor.
- Key dates
Filing, priority, publication, and grant dates set the timeline.
- First independent claim
The legal scope of protection — read this for what is actually claimed.
- CPC / IPC classifications
Technology tags used to group this patent with similar filings.
- Citations and related patents
Prior art links and similar publications in this corpus.
Abstract
Official abstract text for this publication.
The present disclosure relates to methods, devices, and systems used for the treatment of mood, anxiety, cognitive, and behavioral disorders (collectively, neuropsychiatric disorders) via stimulation of the superficial elements of the trigeminal nerve (“TNS”). More specifically, minimally invasive systems, devices and methods of stimulation of the superficial branches of the trigeminal nerve located extracranially in the face, namely the supraorbital, supratrochlear, infraorbital, auriculotemporal, zygomaticotemporal, zygomaticoorbital, zygomaticofacial, nasal and mentalis nerves (also referred to collectively as the superficial trigeminal nerve) are disclosed herein.
First claim
Opening claim text (preview).
What is claimed is: 1. A method for treating a neuropsychiatric disorder by trigeminal nerve stimulation, comprising: implanting a subcutaneous electrode assembly in a patient so that a first electrode contact is in contact with a supraorbital nerve on one side of a patient's forehead and so that a second electrode contact is in contact with a supraorbital nerve on an opposing side of the patient's forehead; and applying electrical signals to the electrode assembly so that curre…
Assignees
Inventors
Classifications
- A61N1/0456Primary
Human Necessities · mapped topic
Human Necessities · mapped topic
Human Necessities · mapped topic
Human Necessities · mapped topic
Human Necessities · mapped topic
Patent family
Related publications grouped by family.
External sources
Next steps
Free tools are coming soon. Tell us what you want to track and we'll notify you.
Frequently asked questions
Answers are generated from the same data shown on this page.
- What does patent US8958880B2 cover?
- The present disclosure relates to methods, devices, and systems used for the treatment of mood, anxiety, cognitive, and behavioral disorders (collectively, neuropsychiatric disorders) via stimulation of the superficial elements of the trigeminal nerve (“TNS”). More specifically, minimally invasive systems, devices and methods of stimulation of the superficial branches of the trigeminal nerve lo…
- Who is the assignee on this patent?
- Degiorgio Christopher, Cook Ian A, Ekchian Leon, and 2 more
- What technology area does this patent fall under?
- Primary CPC classification A61N1/0456. Mapped technology areas include Human Necessities.
- When was this patent published?
- Publication date Tue Feb 17 2015 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
- What related patents are in patentsdb?
- We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).